Clinical Trial Detail

NCT ID NCT03941730
Title Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

triple-receptor negative breast cancer

Therapies

Estradiol

Age Groups: adult senior

No variant requirements are available.